Compare Divis Laboratories with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs FULFORD INDIA - Comparison Results

DIVIS LABORATORIES     Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES FULFORD INDIA DIVIS LABORATORIES/
FULFORD INDIA
 
P/E (TTM) x 34.2 398.8 8.6% View Chart
P/BV x 6.4 6.2 102.3% View Chart
Dividend Yield % 1.0 0.1 1,134.9%  

Financials

 DIVIS LABORATORIES   FULFORD INDIA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-19
FULFORD INDIA
Mar-14
DIVIS LABORATORIES/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs1,639942 174.0%   
Low Rs1,115450 247.8%   
Sales per share (Unadj.) Rs186.3691.4 26.9%  
Earnings per share (Unadj.) Rs51.011.5 444.6%  
Cash flow per share (Unadj.) Rs57.315.4 373.2%  
Dividends per share (Unadj.) Rs16.002.00 800.0%  
Dividend yield (eoy) %1.20.3 404.3%  
Book value per share (Unadj.) Rs261.8380.0 68.9%  
Shares outstanding (eoy) m265.473.90 6,806.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x7.41.0 734.2%   
Avg P/E ratio x27.060.7 44.5%  
P/CF ratio (eoy) x24.045.3 53.0%  
Price / Book Value ratio x5.31.8 287.2%  
Dividend payout %31.417.4 179.9%   
Avg Mkt Cap Rs m365,5922,714 13,468.6%   
No. of employees `00011.80.4 2,668.2%   
Total wages/salary Rs m5,423505 1,073.8%   
Avg. sales/employee Rs Th4,175.16,073.0 68.7%   
Avg. wages/employee Rs Th457.71,137.4 40.2%   
Avg. net profit/employee Rs Th1,141.8100.7 1,134.2%   
INCOME DATA
Net Sales Rs m49,4632,696 1,834.4%  
Other income Rs m1,556125 1,241.1%   
Total revenues Rs m51,0192,822 1,808.0%   
Gross profit Rs m18,718-46 -40,341.4%  
Depreciation Rs m1,68915 11,111.8%   
Interest Rs m3510 368.4%   
Profit before tax Rs m18,55154 34,163.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,02310 52,326.0%   
Profit after tax Rs m13,52745 30,262.6%  
Gross profit margin %37.8-1.7 -2,199.2%  
Effective tax rate %27.117.7 153.2%   
Net profit margin %27.31.7 1,649.7%  
BALANCE SHEET DATA
Current assets Rs m46,5011,738 2,675.1%   
Current liabilities Rs m8,468545 1,554.5%   
Net working cap to sales %76.944.3 173.7%  
Current ratio x5.53.2 172.1%  
Inventory Days Days13148 269.9%  
Debtors Days Days864 1,994.3%  
Net fixed assets Rs m25,79712 216,779.8%   
Share capital Rs m53139 1,361.3%   
"Free" reserves Rs m68,9621,443 4,779.1%   
Net worth Rs m69,4931,482 4,689.1%   
Long term debt Rs m00-   
Total assets Rs m80,3832,077 3,870.7%  
Interest coverage x531.06.7 7,907.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.61.3 47.4%   
Return on assets %16.92.6 646.5%  
Return on equity %19.53.0 645.4%  
Return on capital %26.74.3 621.2%  
Exports to sales %00-   
Imports to sales %24.624.5 100.8%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m12,187659 1,848.5%   
Fx inflow Rs m41,23817 239,753.5%   
Fx outflow Rs m12,405673 1,842.8%   
Net fx Rs m28,833-656 -4,395.5%   
CASH FLOW
From Operations Rs m9,54390 10,603.3%  
From Investments Rs m-6,854105 -6,552.6%  
From Financial Activity Rs m-2,459-14 17,442.6%  
Net Cashflow Rs m230181 127.2%  

Share Holding

Indian Promoters % 52.0 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 11.8 3.8 310.5%  
FIIs % 19.0 0.1 19,000.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.2 21.2 81.1%  
Shareholders   31,796 4,783 664.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   UNICHEM LAB  VENUS REMEDIES  STERLING BIOTECH  WOCKHARDT  AUROBINDO PHARMA  

Compare DIVIS LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 229 Points Lower; Banking and Metal Stocks Witness Selling(Closing)

Indian share markets fell sharply during closing hours today amid weak global cues and disappointing domestic factory output data.

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (2QFY20); Net Profit Down 10.3% (Quarterly Result Update)

Nov 11, 2019 | Updated on Nov 11, 2019

For the quarter ended September 2019, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (down 10.3% YoY). Sales on the other hand came in at Rs 14 bn (up 12.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY19); Net Profit Up 10.6% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 10.6% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (3QFY19); Net Profit Up 68.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 68.9% YoY). Sales on the other hand came in at Rs 13 bn (up 29.4% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Nov 13, 2019 03:37 PM

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 8-QTR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS